NEW DELHI : The covid-19 pandemic has forced the healthcare sector to overhaul doctor-patient interactions, and telemedicine will play a key role to address the challenges going forward, said Ambati Venu, Abbott India’s vice president for pharmaceuticals.
Venu said his company has ramped up production to ensure supply of medicines to patients, and that the government’s focus to boost domestic production of active pharmaceutical ingredients (APIs) could provide more sustainability for both domestic and export markets.
Edited excerpts from an interview in Mint’s Pivot or Perish series:How has the covid-19 pandemic impacted Abbott’s India business so far?The year 2020 has not been one that anyone could have anticipated.